Skip to content
YCW22· AI

Rosebud Biosciences

Growing micro-organs to find new drugs

ActiveChecked 17h ago
Batch
W22
Status, per YC
Active
Team size
3
HQ
San Francisco, CA
In W22398 companies, 44% AI

Founders

Not read from YC yet; the weekly run fills these in.

Same space

About Rosebud Biosciences

Rosebud Biosciences accelerates drug development by screening drugs against organoids (micro-organs) that have the same gene mutations as the patients. We partner with therapeutics companies to screen their drugs, and we perform our own drug discovery for rare diseases that have no existing treatments. Our organoids are also fetal-like and enable discovery of novel drug targets for pediatric diseases. This technology was validated at Stanford, published in a prestigious journal, and has already led to the discovery of a drug target in a pediatric heart disease that could not have been found using traditional disease models.

San Francisco, CA, USA; San Carlos, CA, USA

Rosebud Biosciences: questions

Which YC batch was Rosebud Biosciences in?

Rosebud Biosciences was in Y Combinator's Winter 2022 batch (W22).

Is Rosebud Biosciences still active?

Y Combinator lists Rosebud Biosciences as active.

Where is Rosebud Biosciences based?

Rosebud Biosciences lists San Francisco, CA, USA; San Carlos, CA, USA as its location on YC's directory.

Not affiliated with Y Combinator. From YC's public directory. Logos via logo.dev; trademarks belong to their owners.

Weekly: new YC data, AI and devtools companies and status changes, Mondays.